CME Background Information
To obtain credit, study the material and complete the CME Posttest.
Objective
After completing this educational activity, you should be able to:
- Review multidisciplinary approaches to the routine monitoring and management of obesity and metabolic comorbidities in patients with mental illness.
Statement of Need and Purpose
Individuals with mental illnesses have significantly higher mortality risks due to increased medical comorbidities, especially cardiovascular disease. Despite heightened awareness of the increased prevalence of medical comorbidities and the propensity of atypical antipsychotics to induce metabolic disturbances, monitoring and management of medical comorbidities are not routine among psychiatric practices, even in light of recommendations from published guidelines. This activity was designed to meet the needs of participants in CME activities provided by the CME Institute of Physicians Postgraduate Press, Inc., who have requested information on schizophrenia. There are no prerequisites for participating in this activity.
Accreditation Statement
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The CME Institute of Physicians Postgraduate Press, Inc. designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Date of Original Release/Review
This E-View was published in May 2007 and is eligible for AMA PRA Category 1 Credit through May 31, 2009. The latest review of this material was March 2007.
Faculty Disclosure
In the spirit of full disclosure and in compliance with all ACCME Essential Areas and Policies, the faculty for this CME activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest (i.e., any proprietary entity producing health care goods or services consumed by, or used on, patients) occurring within the 12 months prior to joining this activity. The CME Institute has resolved any conflicts of interest that were identified. The disclosures are as follows:
Dr. Newcomer has received grant/research support from The National Institute of Mental Health, The National Alliance for Research on Schizophrenia and Depression, the Sidney R. Baer Jr. Foundation, Janssen, Pfizer, Bristol-Myers Squibb, and Wyeth, and is a consultant for Janssen, Pfizer, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Organon, litigation, Compact Clinicals, Solvay, and Wyeth.
Dr. Ganguli has received grant/research support from The National Institute of Mental Health, the Stanley Medical Research Institute, Eli Lilly, Janssen, Bristol-Myers Squibb, and the Trunzo Family Fund; is a consultant for Janssen, Bristol-Myers Squibb, Pfizer, and Eli Lilly; and has received speakers honoraria from Eli Lilly, Bristol-Myers Squibb, Janssen, Pfizer, and AstraZeneca.
Ms. Vreeland has received grant/research support from Eli Lilly, is a consultant for Eli Lilly; is a member of the speakers/advisory boards of Bristol-Myers Squibb and Eli Lilly, and her University has received fees for these services; and is a stock shareholder of Johnson & Johnson and Pfizer.
Disclosure of Off-Label Usage
Dr. Ganguli has determined that, to the best of his knowledge, no investigational information about pharmaceutical agents that is outside U.S. Food and Drug Administration-approved labeling has been presented in this actitvity
Review Process
This activity has undergone a 3-tier review process: (1) the entire faculty of the series discussed the content at a peer-review planning session; (2) the Chair reviewed the activity for accuracy and fair balance; and (3) a member of the External CME Advisory Board reviewed the activity to determine whether the material is evidence-based and objective.
Acknowledgment
This E-View is derived from the planning roundtable “Strategies to Integrate Physical Health Care Into Mental Health,” which was held August 28, 2006, in Philadelphia, Pa., and was independently developed by the CME Institute of Physicians Postgraduate Press, Inc., and Letters & Sciences pursuant to an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc. The opinions expressed herein are those of the faculty and do not necessarily reflect the opinions of the CME provider and publisher, Letters & Sciences, or the commercial supporter.